Acadia Pharmaceutica Correlations

ACAD
 Stock
  

USD 16.40  0.66  4.19%   

The correlation of Acadia Pharmaceutica is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Acadia Pharmaceutica moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Acadia Pharmaceutica moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Please continue to Trending Equities.
  
The ability to find closely correlated positions to Acadia Pharmaceutica could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Acadia Pharmaceutica when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Acadia Pharmaceutica - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Acadia Pharmaceutica to buy it.

Moving together with Acadia Pharmaceutica

0.64ACERAcer TherapeuticsPairCorr

Related Correlations

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

The Correlation Coefficient is a useful tool to identify correlated or non-correlated securities, which is essential in developing a diversified portfolio. It tells us the relationship between two positions you have in your portfolio or considering acquiring. Over a given time period, the two securities movetogether when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
FUBER
AMSFT
FMSFT
AF
UBERMSFT
XOMJPM
  
High negative correlations   

Acadia Pharmaceutica Competition Risk-Adjusted Indicators

Nowadays, there is a big difference between Acadia Pharmaceutica stock performing well and Acadia Pharmaceutica company doing well compared to the competition. There are way too many exceptions to the normal that investors can tell for sure what's good or bad unless they analyze Acadia Pharmaceutica's multiple risk-adjusted performance indicators. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean
Deviation
Jensen
Alpha
Sortino
Ratio
Treynor
Ratio
Semi
Deviation
Information
Ratio
Expected
Shortfall
Potential
Upside
Value
At Risk
Maximum
Drawdown
TWTR 2.27 (0.12)  0.00 (0.06)  0.00 (0.0394)  0.00  4.00 (5.55)  17.65 
MSFT 1.64  0.04  0.03  0.10  2.02  0.0309 (1.74)  2.97 (4.10)  7.83 
UBER 3.49  0.45  0.11  0.34  3.87  0.11 (3.67)  6.40 (7.08)  21.38 
F 2.62  0.20  0.09  0.17  2.90  0.09 (2.81)  5.32 (4.03)  16.84 
T 1.11 (0.11)  0.00 (0.10)  0.00 (0.08)  0.00  2.00 (2.45)  10.60 
A 1.80  0.14  0.08  0.18  1.89  0.07 (2.03)  4.22 (3.15)  8.98 
CRM 2.46  0.11  0.06  0.13  2.83  0.05 (2.70)  5.77 (4.63)  16.84 
JPM 1.45 (0.02) (0.01)  0.05  1.52 (0.0055) (1.78)  3.03 (2.34)  10.79 
MRK 1.00  0.04  0.00  0.17  1.21 (0.0045) (1.05)  2.11 (2.50)  6.96 
XOM 1.94  0.14  0.05  0.23  2.59  0.05 (1.86)  3.33 (3.96)  10.43 

Be your own money manager

Our tools can tell you how much better you can do entering a position in Acadia Pharmaceutica without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Positions Ratings Now

   

Positions Ratings

Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
All  Next Launch Module

Acadia Pharmaceutica Corporate Directors

Acadia Pharmaceutica corporate directors refer to members of an Acadia Pharmaceutica board of directors. The board of directors generally takes responsibility for the Acadia Pharmaceutica's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Acadia Pharmaceutica's board members must vote for the resolution. The Acadia Pharmaceutica board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Mary Gray - Independent DirectorProfile
Daniel Soland - DirectorProfile
Stephen Biggar - Independent DirectorProfile
William Wells - Independent DirectorProfile

Invested in Acadia Pharmaceutica?

You need to understand the risk of investing before taking a position in Acadia Pharmaceutica. The danger of trading Acadia Pharmaceutica is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Acadia Pharmaceutica is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Acadia Pharmaceutica. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Acadia Pharmaceutica is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Please continue to Trending Equities. Note that the Acadia Pharmaceutica information on this page should be used as a complementary analysis to other Acadia Pharmaceutica's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Complementary Tools for Acadia Stock analysis

When running Acadia Pharmaceutica price analysis, check to measure Acadia Pharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acadia Pharmaceutica is operating at the current time. Most of Acadia Pharmaceutica's value examination focuses on studying past and present price action to predict the probability of Acadia Pharmaceutica's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Acadia Pharmaceutica's price. Additionally, you may evaluate how the addition of Acadia Pharmaceutica to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Is Acadia Pharmaceutica's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Acadia Pharmaceutica. If investors know Acadia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Acadia Pharmaceutica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
2.6 B
Quarterly Revenue Growth YOY
0.17
Return On Assets
-0.19
Return On Equity
-0.41
The market value of Acadia Pharmaceutica is measured differently than its book value, which is the value of Acadia that is recorded on the company's balance sheet. Investors also form their own opinion of Acadia Pharmaceutica's value that differs from its market value or its book value, called intrinsic value, which is Acadia Pharmaceutica's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Acadia Pharmaceutica's market value can be influenced by many factors that don't directly affect Acadia Pharmaceutica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Acadia Pharmaceutica's value and its price as these two are different measures arrived at by different means. Investors typically determine Acadia Pharmaceutica value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Acadia Pharmaceutica's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.